Team
Julià Agramunt

Julià Agramunt

Ph.D.

Postdoctoral Fellow

I am Dr. Julià Agramunt, a bioengineer with a PhD from Imperial College London (2022), where I investigated the role of hair follicles in tactile sensation. Funded by Procter & Gamble’s prestigious £97,000 (≈892,400 CNY) iCASE award, my work challenged  established  neuroscience  paradigms  and  was published  in Science Advances (2023). This research gained widespread recognition, including a feature in The New York Times under the headline, “Tingly All Over: A Hairy Truth About Your Sense of Touch.”My  academic  journey began  with  a  BSc  in  Experimental  Psychology  from  the University of Barcelona (2016), followed by an MSc in Molecular Neuroscience from the University of Bristol (2017). During my MSc, I investigated the pharmacodynamics of  a  novel drug  targeting   NMDA  receptors,  with   implications  for   memory   and depression treatment. This work explored the drug’s ***-like effects and its potential as a therapeutic agent for mood disorders.In  2024,  I co-invented two European patents focused on dermatology  and pharmacology. I led all data generation in the lab and contributed to the intellectual property  development,  resulting in the discovery of two previously unknown compounds with significant potential for  treating hair loss and skin pigmentation disorders.Beyond research,  I  have  mentored  numerous  MSc students and taught two PhD students, both of whom have continued my PhD work within my research group at Imperial College London.Throughout my career, I have been recognised for my contributions to science and leadership.  I received the Best Talk Award at the 2019 European  Neuroscience Conference and a £2,000 (≈18,400 CNY) grant from the European Hair Research Society (2018) for developing innovative volumetric immunostaining techniques for skin research. Additionally, I was awarded €4,800 (≈36,480 CNY) by the University of Barcelona (2014) for investigating numerical cognition.Beyond research, I served as the PhD Representative at Imperial College London, where I represented all PhD students from my department, promoting collaboration and improving academic support systems. Finally, in 2022, I was selected as one of 27 participants from a pool of 1,000 applicants for the prestigious PhD R&D Procter & Gamble seminar in Germany.

Oshrat

Oshrat

Ph.D.

Postdoctoral Fellow

I am a biologist with a background in animal sciences (B.Sc.Agr.), marine biology (M.Sc.), and evolutionary biology (Ph.D.). For over a decade, my research has focused on the colonial invertebrate Botryllus schlosseri, a powerful model organism for investigating fundamental processes, including aging, regeneration, rejuvenation, stem cell biology, immunology, and chimerism.My work has contributed insights across several levels of biology. I identified and characterized the “Orshina Rhythm,” a recurring pattern of aging and rejuvenation tied to reproduction and fission events in Botryllus. I demonstrated that the stress protein mortalin orchestrates cyclic aging and regeneration at the module level, regulating growth and colonial development through the blastogenic cycle. I also co-authored a book chapter presenting the life history, biology, and anatomy of Botryllus, in which it is discussed as an emerging model organism with significant potential for both basic biology and regenerative medicine.In addition, I investigate aging theories in practice, focusing on the role of cellular waste as a contributor to aging, particularly lipofuscin, which is studied as a marker and potential trigger of module senescence. I am currently characterizing gene expression programs that govern cycles of aging, rejuvenation, and regeneration, and I also explore ecological and evolutionary strategies such as chimerism, which enhance resilience under stress.By integrating long-term organismal tracking with molecular, cellular, and histological approaches, I aim to uncover unifying principles of aging and regeneration, and to translate these discoveries into insights relevant for medical regeneration.